These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30358401)

  • 21. Mechanisms of conotoxin inhibition of N-type (Ca(v)2.2) calcium channels.
    Adams DJ; Berecki G
    Biochim Biophys Acta; 2013 Jul; 1828(7):1619-28. PubMed ID: 23380425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scanning mutagenesis of alpha-conotoxin Vc1.1 reveals residues crucial for activity at the alpha9alpha10 nicotinic acetylcholine receptor.
    Halai R; Clark RJ; Nevin ST; Jensen JE; Adams DJ; Craik DJ
    J Biol Chem; 2009 Jul; 284(30):20275-84. PubMed ID: 19447885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. α-Conotoxin Vc1.1 Structure-Activity Relationship at the Human α9α10 Nicotinic Acetylcholine Receptor Investigated by Minimal Side Chain Replacement.
    Chu X; Tae HS; Xu Q; Jiang T; Adams DJ; Yu R
    ACS Chem Neurosci; 2019 Oct; 10(10):4328-4336. PubMed ID: 31411453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-Activity Studies of Cysteine-Rich α-Conotoxins that Inhibit High-Voltage-Activated Calcium Channels via GABA(B) Receptor Activation Reveal a Minimal Functional Motif.
    Carstens BB; Berecki G; Daniel JT; Lee HS; Jackson KA; Tae HS; Sadeghi M; Castro J; O'Donnell T; Deiteren A; Brierley SM; Craik DJ; Adams DJ; Clark RJ
    Angew Chem Int Ed Engl; 2016 Apr; 55(15):4692-6. PubMed ID: 26948522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presence of multiple binding sites on α9α10 nAChR receptors alludes to stoichiometric-dependent action of the α-conotoxin, Vc1.1.
    Indurthi DC; Pera E; Kim HL; Chu C; McLeod MD; McIntosh JM; Absalom NL; Chebib M
    Biochem Pharmacol; 2014 May; 89(1):131-40. PubMed ID: 24548457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of rat α9α10 nicotinic acetylcholine receptor with α-conotoxin RgIA and Vc1.1: Insights from docking, molecular dynamics and binding free energy contributions.
    Li R; Li X; Jiang J; Tian Y; Liu D; Zhangsun D; Fu Y; Wu Y; Luo S
    J Mol Graph Model; 2019 Nov; 92():55-64. PubMed ID: 31330438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Less is More: Design of a Highly Stable Disulfide-Deleted Mutant of Analgesic Cyclic α-Conotoxin Vc1.1.
    Yu R; Seymour VA; Berecki G; Jia X; Akcan M; Adams DJ; Kaas Q; Craik DJ
    Sci Rep; 2015 Aug; 5():13264. PubMed ID: 26290113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are alpha9alpha10 nicotinic acetylcholine receptors a pain target for alpha-conotoxins?
    Nevin ST; Clark RJ; Klimis H; Christie MJ; Craik DJ; Adams DJ
    Mol Pharmacol; 2007 Dec; 72(6):1406-10. PubMed ID: 17804600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-conotoxin Vc1.1 alleviates neuropathic pain and accelerates functional recovery of injured neurones.
    Satkunanathan N; Livett B; Gayler K; Sandall D; Down J; Khalil Z
    Brain Res; 2005 Oct; 1059(2):149-58. PubMed ID: 16182258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of arginine 10 to lysine substitution on ω-conotoxin CVIE and CVIF block of Cav2.2 channels.
    Berecki G; Daly NL; Huang YH; Vink S; Craik DJ; Alewood PF; Adams DJ
    Br J Pharmacol; 2014 Jul; 171(13):3313-27. PubMed ID: 24628243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analgesic (omega)-conotoxins CVIE and CVIF selectively and voltage-dependently block recombinant and native N-type calcium channels.
    Berecki G; Motin L; Haythornthwaite A; Vink S; Bansal P; Drinkwater R; Wang CI; Moretta M; Lewis RJ; Alewood PF; Christie MJ; Adams DJ
    Mol Pharmacol; 2010 Feb; 77(2):139-48. PubMed ID: 19892914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dicarba analogues of α-conotoxin RgIA. Structure, stability, and activity at potential pain targets.
    Chhabra S; Belgi A; Bartels P; van Lierop BJ; Robinson SD; Kompella SN; Hung A; Callaghan BP; Adams DJ; Robinson AJ; Norton RS
    J Med Chem; 2014 Dec; 57(23):9933-44. PubMed ID: 25393758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel analgesic ω-conotoxins from the vermivorous cone snail Conus moncuri provide new insights into the evolution of conopeptides.
    Sousa SR; McArthur JR; Brust A; Bhola RF; Rosengren KJ; Ragnarsson L; Dutertre S; Alewood PF; Christie MJ; Adams DJ; Vetter I; Lewis RJ
    Sci Rep; 2018 Sep; 8(1):13397. PubMed ID: 30194442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analgesic conopeptides targeting G protein-coupled receptors reduce excitability of sensory neurons.
    Sadeghi M; McArthur JR; Finol-Urdaneta RK; Adams DJ
    Neuropharmacology; 2017 Dec; 127():116-123. PubMed ID: 28533165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiallodynic effects of a confused α-conotoxin: Vc1.1 relieves neuropathic pain via off target actions on GABA(B) receptors and N-type channels.
    Zamponi GW
    Pain; 2011 Feb; 152(2):241-242. PubMed ID: 20880631
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecular Determinants Conferring the Stoichiometric-Dependent Activity of α-Conotoxins at the Human α9α10 Nicotinic Acetylcholine Receptor Subtype.
    Yu R; Tae HS; Tabassum N; Shi J; Jiang T; Adams DJ
    J Med Chem; 2018 May; 61(10):4628-4634. PubMed ID: 29733583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Conus regularis conotoxin with a novel eight-cysteine framework inhibits CaV2.2 channels and displays an anti-nociceptive activity.
    Bernáldez J; Román-González SA; Martínez O; Jiménez S; Vivas O; Arenas I; Corzo G; Arreguín R; García DE; Possani LD; Licea A
    Mar Drugs; 2013 Apr; 11(4):1188-202. PubMed ID: 23567319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limited efficacy of α-conopeptides, Vc1.1 and RgIA, to inhibit sensory neuron Ca
    Wright AB; Norimatsu Y; McIntosh JM; Elmslie KS
    eNeuro; 2015; 2(1):. PubMed ID: 26078999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of the α-conotoxin Vc1.1 binding site on the α9α10 nicotinic acetylcholine receptor.
    Yu R; Kompella SN; Adams DJ; Craik DJ; Kaas Q
    J Med Chem; 2013 May; 56(9):3557-67. PubMed ID: 23566299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of cyclization on stability, structure, and activity of α-conotoxin RgIA at the α9α10 nicotinic acetylcholine receptor and GABA(B) receptor.
    Halai R; Callaghan B; Daly NL; Clark RJ; Adams DJ; Craik DJ
    J Med Chem; 2011 Oct; 54(19):6984-92. PubMed ID: 21888386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.